Medical expert of the article
New publications
Hypothymia: Symptoms, Causes, and Treatment
Last updated: 27.10.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Hypothymia is a persistent depression of mood with a weakening of emotional "feedback," sometimes accompanied by a slowing of mental and motor activity. It is not an independent diagnosis, but a symptom and component of various conditions—primarily depressive disorders. In the Russian-language clinical tradition, hypothymia is described as a "minus emotion," similar to sadness, melancholy, and emotional emptiness.
It is important to distinguish hypothymia as a normal, short-term reaction (e.g., to loss or stress) from a clinically significant disorder, where the depressed mood is persistent, recurring, and disrupts daily functioning. In current practice, this is defined by the criteria for an episode of depression or adjustment disorder if the symptoms are "tied" to a specific stressor. [2]
The term "hypothymia" is also found in dictionaries and reference books as "decreased affect" or "weakened emotional response," reflecting its symptomatic nature. In English-language sources, "hypothymia" is described as a depressive state or reduced emotional response. These definitions are convenient for describing the phenomenology but do not replace diagnostic categories. [3]
Understanding hypothymia is useful for patients and professionals: it is a “core” feature of depression, affects the risk of suicidality and quality of life, and determines the choice of tactics - from observation and psychoeducation to structured psychotherapy and pharmacotherapy. [4]
Code according to ICD-10 and ICD-11
In the International Classification of Diseases, Eleventh Revision (ICD-11), the symptom of hypothymia is included in the description of a depressive episode and depressive disorders: one or more episodes with a predominantly depressed mood and/or anhedonia, combined with cognitive and neurovegetative symptoms. There is no separate code for "hypothymia" in ICD-11; the episode/disorder is coded. [5]
In ICD-10, depressed mood is also included in the criteria for "Depressive Episode" (F32.x) and "Recurrent Depressive Disorder" (F33.x). When referring solely to a symptom without a recognized mental disorder, some systems allow the use of "symptom" codes R45 ("symptoms and signs associated with emotional state"), such as R45.2 "Unhappiness/feeling of unhappiness." The decision on the code depends on the clinical setting and context. [6]
For "reactive" patterns, when depressed mood is closely linked to a specific stressor and "fixation on the stressor" and "adaptation failure" predominate, "Adjustment disorder" is used: ICD-11 - 6B43; in ICD-10 - F43.2x (including F43.21 "with depressive mood"). This helps to distinguish subsyndromal reactions from a depressive episode. [7]
Certain clinical situations (e.g., chronically depressed mood for ≥2 years) fall under the category "persistent depressive states" in ICD-11; in ICD-10, it is dysthymia (F34.1). The choice of code determines the routing and scope of care. [8]
Table 1. How clinically significant hypothymia is coded
| Situation | ICD-11 | ICD-10 | Note |
|---|---|---|---|
| Complete depressive episode | 6A70 (single), 6A71 (recurrent) | F32.x / F33.x | Depressed mood + other symptoms, ≥2 weeks |
| Response to stress with "adaptation failure" | 6B43 | F43.2x | If it does not reach the threshold of a depressive episode |
| Long-term depressed mood (persistent) | (persistent depressive) | F34.1 | By duration and severity |
| Isolated symptom without diagnosis | - | R45.2 (feeling of unhappiness) | Used as a symptom code according to indications |
| Source. [9] |
Epidemiology
Globally, depressive disorders (in which hypothymia is a key symptom) occur in approximately 3.8% of the population, including 5% of adults; this equates to approximately 280–332 million people, depending on estimates and years. Prevalence is higher in women and in older people. [10]
According to the US National Institute of Mental Health, approximately 8.3% of adults have experienced at least one major depressive episode in the past year; 10.3% of women and 6.2% of men; the highest rates are among those aged 18–25 years (≈18.6%). These data illustrate the “potential” for hypothymia in the population. [11]
In a number of European countries, the prevalence of depressive disorders exceeds 5% of the population, highlighting the importance of systemic measures for identification and assistance. It should be remembered that the choice of methodology (questionnaires vs. clinical interviews) influences prevalence estimates. [12]
In adjustment disorder (often starting with hypothymia associated with a stressor), the prevalence in vulnerable groups (for example, after injuries or in oncology) can reach double-digit values, especially in the first months after the event. [13]
Table 2. Illustrative epidemiological guidelines
| Indicator | Meaning | Source |
|---|---|---|
| Global prevalence of depression | ≈3.8-5.0% of adults | [14] |
| Globally, people live with depression. | ≈280-332 million | [15] |
| US: Adults with an episode per year | 8.3% | [16] |
| Peak age | 18-25 years old | [17] |
Reasons
Hypothymia arises from a combination of biological and psychosocial factors. At the biological level, mood regulation circuits (prefrontal cortex, cingulate cortex, limbic structures) and neurotransmitter systems (serotonin, norepinephrine, dopamine) are involved. These mechanisms also underlie the effectiveness of antidepressants and neuromodulation. [18]
Psychological mechanisms include ruminative thinking, negative cognitive schemas, and avoidance behavior—they maintain and deepen the decline in mood after stressors or failures. Targeted psychotherapy aims to break these “loops.” [19]
Social determinants (unemployment, poverty, loneliness, chronic caregiving) exacerbate and prolong hypothymia. Support networks, daily routine, and physical activity have a protective effect. [20]
In some people, hypothymia starts as a “stress reaction” and evolves into a clinical disorder if “fixation on the stressor” and “failure to adapt” persist, or predisposing factors are superimposed. [21]
Risk factors
A family history of depression, female gender, adolescence and young adulthood, chronic somatic illnesses and pain, sleep disorders, and substance use all increase the likelihood of clinically significant hypothymia. [22]
Recent or chronic stressors (bereavement, divorce, financial instability) and low social support increase the risk of adjustment disorder and depression. Early intervention reduces the likelihood of chronicity. [23]
Traumatic events and prolonged uncertainty increase vulnerability to mood decline even in people without previous episodes. Coping strategies and access to help modify the risk. [24]
Subtle but persistent sleep disturbances increase the likelihood of persistent “minus affect”, so sleep hygiene is a basic element of prevention and treatment. [25]
Pathogenesis
The ICD-11 systemic view: depressive episodes are described by clusters of symptoms—affective (hypothymia, anhedonia), cognitive (guilt, hopelessness), behavioral, and neurovegetative (sleep, appetite, energy). Hypothymia is the leading symptom in this cluster. [26]
At the neural network level, the "up-regulation" of positive affect is reduced and inhibitory control of negative attention is disrupted; ruminative information processing is enhanced. This explains the stability of the "minus mood" and the benefits of behavioral activation. [27]
Hyperactivation of stress systems (hypothalamic-pituitary-adrenal axis) and circadian shifts support depressive physiology: sleep architecture changes, daytime energy decreases, and emotional grayness increases. [28]
In resistant cases, methods that affect the mood network without medication (rTMS, TBS) are effective, which confirms the neural network nature of the symptom. [29]
Symptoms
The core is a persistent (most days) decline in mood: sadness, melancholy, "emotional flatness," loss of color in life. Often combined with anhedonia—loss of interest and pleasure in familiar activities.
Cognitive manifestations: guilt, self-reproach, hopelessness, decreased concentration and speed of thought, indecision. These symptoms reinforce and perpetuate hypothymia.
Neurovegetative and somatic signs: sleep disturbances (insomnia or hypersomnia), changes in appetite and body weight, fatigue, psychomotor retardation or agitation, pain without a clear somatic cause.
Functional consequences: decreased performance at work/school, social withdrawal, difficulty with self-care. If worsening, suicidal ideation may occur, requiring immediate safety assessment. [33]
Table 3. Hypothymia vs. normal sadness
| Sign | Normal sadness | Clinical hypothymia (as part of the diagnosis) |
|---|---|---|
| Duration | days → waning | ≥2 weeks, often longer |
| Functioning | saved | disrupted (work, everyday life, studies) |
| Additional symptoms | moderate | cognitive and autonomic clusters |
| Do you need help? | observation | clinical assessment and treatment |
| Source. [34] |
Classification, forms and stages
ICD-11 distinguishes between: depressive episode (6A7x) - one event; single depressive disorder (6A70) - the current episode; recurrent (6A71) - ≥2 episodes with remissions. In all cases, hypothymia is a possible leading symptom. [35]
The severity of a depressive episode is classified as mild, moderate, or severe (based on the number and severity of symptoms and functional impairments). This determines the choice of treatment methods, from first-line psychotherapy to combined strategies. [36]
If the mood decline is "tied" to a stressor and "fixation" and "adaptation failure" predominate, "Adjustment Disorder" is used. This helps avoid overdiagnosing depression when the clinical picture is subthreshold. [37]
Chronically depressed mood (≥2 years) falls under the category of "persistent depressive states" (dysthymia in ICD-10). The clinical picture is less severe, but long-lasting and reduces quality of life. [38]
Table 4. Where does hypothymia fall into classifications?
| Clinical context | Heading |
|---|---|
| Full set of depressive symptoms ≥2 weeks | Depressive episode/depressive disorder (ICD-11 6A70-6A71) |
| Attachment to a stressor, subthreshold picture | Adjustment disorder (ICD-11 6B43) |
| Long-term depressed mood ≥2 years | Persistent depressive disorder/dysthymia |
| Source. [39] |
Complications and consequences
Untreated hypothymia in depression is associated with risks such as suicidality, job/study loss, relationship breakdown, and somatic complications (e.g., worsening cardiovascular disease). The longer the episode, the greater the burden. [40]
Subsyndromal hypothymia can "lower the trajectory" of life: increasing the likelihood of alcohol abuse, contributing to chronic insomnia, and reducing physical activity. This is often underestimated, although preventive interventions are effective. [41]
In adjustment disorder, risks include prolonged decline in functioning and suicidal behavior, especially in the first months after the stressor. Early screening and access to brief psychotherapies are needed. [42]
A relapsing course without support forms a “despair habit”: ruminative cycles intensify, confidence in symptom control decreases – therefore, a maintenance plan and “stepped” assistance are important. [43]
When to see a doctor
If depressed mood persists for ≥2 weeks, affects work/study/everyday life, and is accompanied by disturbances in sleep, appetite, energy, or obsessive self-reproach, a clinical assessment and discussion of treatment options are needed. [44]
Contact immediately if you experience suicidal thoughts, plans, severe hopelessness, or inability to perform basic self-care. Safety is a priority; treatment is discussed after stabilization. [45]
If your mood decline is related to a recent stressor and is "spinning around in your head," it makes sense to discuss adjustment disorder and short-term focused psychotherapy. This helps "intercept" a protracted course. [46]
Recurring episodes are a reason for relapse prevention: a maintenance plan, early signs of deterioration, regular “check-ins” with a doctor/therapist. [47]
Diagnostics
The first step is a clinical interview: duration, severity, and context of hypothymia; assessment of cognitive/autonomic symptoms and impact on function; screening for suicidal risk. At the same time, stressors, resources, sleep, substances, and medications are identified. [48]
The second step is to define the framework: the criteria for a depressive episode (ICD-11) or adjustment disorder (with a “fixation” on the stressor and a “breakdown in adaptation”). The severity and presence of relapses are recorded. [49]
The third step is screening tools according to indications: PHQ-9/PHQ-2 for primary care (PHQ-9 ≥10 - sensitivity/specificity about 0.88/0.88 according to one data; meta-analyses provide a range), with mandatory clinical confirmation. [50]
The fourth step is a basic somatic screening if necessary (thyroid, deficiencies, drug effects), sleep and pain assessment; instrumental methods (e.g., neuroimaging) - strictly as indicated. Next - a joint decision on the care plan. [51]
Table 5. Diagnostic minimum for hypothymia
| Step | What are we doing? | For what |
|---|---|---|
| Interview | symptoms, duration, functions, risk | verify clinical significance |
| Classification | ICD-11: Depression vs. Adjustment Disorder | set a treatment route |
| Screening | PHQ-2/PHQ-9 (+ confirmation) | quantify the severity |
| Somatic minimum | according to indications | security and targeted correction |
| Source. [52] |
Differential diagnosis
A normal grief/stress reaction is a depressed mood with gradual improvement, with functions generally preserved. If symptoms persist and adaptation fails, an adjustment disorder or depressive episode is considered. [53]
Anxiety disorders are characterized by predominant anxiety, tension, and avoidance; depressed mood is secondary. The approach is shifting toward anti-anxiety psychotherapies; in cases of comorbidity, approaches are combined. [54]
Somatic causes (endocrine, neurological, drug side effects, deficiencies) can mimic hypothymia; somatic screening and coordination with a therapist are critical here. [55]
Bipolar spectrum disorder – a history of episodes of elevation (hypomania/mania, mixed states). In ICD-11, these are separate categories; treatment options vary, so a detailed history is essential. [56]
Table 6. What distinguishes states with a decrease in mood
| State | Leading signs | First line tactics |
|---|---|---|
| Normal reaction | transient sadness, functions preserved | observation, psychoeducation |
| Adjustment disorder | "fixation" + adaptation failure | brief psychotherapies |
| Depressive episode | ≥2 weeks + symptom clusters | step-down treatment (NICE) |
| Bipolar disorder | history of hypomania/mania | profile tactics, be careful with antidepressants |
| Source. [57] |
Treatment
The goals are to elevate mood to a functionally acceptable level, restore interest and energy, reduce ruminativeness, and reduce the risk of relapse. The approach is always individualized and developed in collaboration with the patient, taking into account preferences and severity. In "stepped care" models, treatments begin with less invasive interventions and increase in intensity as needed. [58]
Psychoeducation is the foundation: we explain that hypothymia is part of a predictable cluster, and "small steps" work. We discuss sleep, rhythm, physical activity, nutrition, and limiting alcohol and nicotine. We formulate initial achievable goals and a monitoring plan. [59]
First-line psychotherapy for mild/moderate depression and adjustment disorder: cognitive behavioral therapy, interpersonal therapy, behavioral activation, problem solving; blended/digital formats are acceptable. Choice depends on availability and demand. Efficacy is confirmed by current guidelines. [60]
If hypothymia is part of a more severe depression, pharmacotherapy is discussed as part of a combination plan. First-line medications include selective serotonin reuptake inhibitors and other antidepressants based on clinical indications and tolerability. The decision is made collaboratively, with information on the benefit/risk profile and the duration of effect. [61]
Safety monitoring is mandatory: suicidal risk, adverse events, sleep, appetite, and drug side effects. Initial reassessment is performed after 2-4 weeks, and then according to clinical findings. If a partial response is observed, the dose/drug is adjusted and psychotherapy is intensified. [62]
Neuromodulation is used for treatment-resistant depression: rTMS (high-frequency on the left) and intermittent theta-burst stimulation; meta-analyses confirm their effectiveness and acceptable tolerability. These methods act on the frontal-limbic networks, where hypothymia resides. [63]
Supportive approaches include addressing social determinants (finances, employment, caregiving), coordinating with primary care physicians, and teaching relatives not to overburden them with excessive care and discouraging avoidance. This reduces environmental pressure and accelerates recovery. [64]
For "reactive" cases (6B43), brief, focused interventions are optimal: working with ruminativeness and problems, planning adaptation steps. Early intervention significantly reduces the duration of hypothymia and the risk of developing a depressive episode. Medication is not the first line of treatment. [65]
Maintenance plan after improvement: a written checklist of early signs (sleep, interest, energy), a schedule of "microactivations," and an arrangement for follow-up visits. Regular "small doses" of activity and social contacts reduce the likelihood of hypothymia returning. [66]
In the presence of comorbid anxiety or insomnia, sleep and stress are stabilized first (behavioral techniques, CBT-I, sleep hygiene), then antidepressant blocks are intensified. This sequence increases tolerance and adherence. [67]
Table 7. Key elements of treatment for hypothymia
| Component | Examples | Target |
|---|---|---|
| Psychoeducation + regime | sleep, rhythm, movement | "enable" recovery |
| Psychotherapy | CBT, MBT, behavioral activation | work specifically with the "minus affect" |
| Pharmacotherapy | SSRIs and others (as indicated) | for moderate to severe depression |
| Neuromodulation | rTMS, iTBS | in case of resistance |
| Maintenance | relapse prevention plan | reduce the risk of return |
| Source. [68] |
Prevention
Primary prevention includes sleep hygiene, regular physical activity, social inclusion, alcohol limitation, and stress and debt management. These simple measures reduce the likelihood of temporary hypothyroidism progressing to a clinical condition. [69]
Secondary - early screening for hypothymia in primary care (short questionnaires, targeted mood questions), with rapid provision of low-threshold psychotherapy/digital modules. This is especially important after significant stressors. [70]
Organizational measures - access to guidelines and step-by-step pathways (NICE NG222, updated WHO mhGAP): these reduce barriers to entry into care and improve population-level outcomes. [71]
Supportive “microsteps” (daily walks, contact with loved ones, short plans for the day) and digital reminders help prevent “sliding” into passivity and maintain emotional tone. [72]
Forecast
For mild/moderate depression and adjustment disorder, the prognosis is favorable with early initiation of psychotherapy and normalization of the regimen: improvement often occurs within weeks. Without treatment, the risk of protracted illness and relapse is higher. [73]
In more severe episodes, combination strategies (psychotherapy + pharmacotherapy, in case of resistance - neuromodulation) provide a high chance of remission and restoration of functions with good adherence. [74]
Unfavorable prognostic factors include persistent stress, chronic somatic diseases, severe insomnia, social isolation, and the absence of a support plan. Targeted correction of these factors significantly improves long-term outcomes. [75]
Even with recurrent episodes, patients learn to recognize early signals and “catch” the decline in mood, which reduces the duration of episodes and their impact on life. [76]
FAQ
Is hypothymia a diagnosis?
No. It's a symptom (low mood). In medical records, they code for depressive episode/disorder, adjustment disorder, or use symptom codes in special cases. [77]
How long does "normal" sadness last, and when does it become a medical condition?
If the depressed mood lasts for ≥2 weeks, disrupts daily life, and is accompanied by other depressive symptoms, a clinical assessment for depression/adjustment disorder is needed. [78]
Do I need medication if I'm "just" depressed?
For mild/subthreshold mood swings, psychotherapy and lifestyle modification are the first choice. Medication is considered for more severe symptoms or if non-drug measures are ineffective. [79]
What should you do right now if everything is gray?
Establish a sleep schedule (regular wake-up/go-to-bedtime), take a small, planned step of activity, contact a loved one, and schedule a consultation. If you're experiencing suicidal thoughts, seek immediate emergency help. [80]
Additional tables
Table 8. Rapid markers of severity in hypothymia
| Marker | Light | Moderate | Heavy |
|---|---|---|---|
| Duration | <2 weeks | ≥2-8 weeks | ≥8 weeks |
| Functioning | almost saved | noticeably reduced | sharply violated |
| Associated symptoms | few | several clusters | many clusters + suicidality |
| Tactics | psychoeducation, activation | psychotherapy | combo approach (psycho + pharma ± rTMS) |
| Source. [81] |
Table 9. Screening tools and their properties
| Tool | For whom | Accuracy ranges |
|---|---|---|
| PHQ-2 | primary care | sensitivity ≈0.83-0.87; specificity ≈0.78-0.92 |
| PHQ-9 | all adults | at a threshold of ≥10: sensitivity/specificity ≈0.88/0.88 (varies across meta-analyses) |
| Source. [82] |
Table 10. 14-day self-help package for hypothymia
| Day | Step | Example |
|---|---|---|
| 1-3 | Dream | fixed wake-up/light-out, morning light |
| 4-7 | Activation | 20 minutes walk daily |
| 8-10 | Cognitions | recording "minus thoughts" → alternatives |
| 11-14 | Social contact | 2 calls/meetings + plan for next week |
| Source. [83] |
Who to contact?

